Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation.
作者信息
Boonyasai Romsai T, Murthy Vivek Krishna, Yuen-Gee Liu Gigi, Garibaldi Brian T, Brotman Daniel J, Streiff Michael B, Omron Rodney
机构信息
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
出版信息
Mayo Clin Proc. 2020 Oct;95(10):2291-2293. doi: 10.1016/j.mayocp.2020.08.014. Epub 2020 Aug 13.
Abstract
摘要
相似文献
1
Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation.接受预防性抗凝治疗的新冠肺炎住院患者的静脉血栓栓塞症
Mayo Clin Proc. 2020 Oct;95(10):2291-2293. doi: 10.1016/j.mayocp.2020.08.014. Epub 2020 Aug 13.
2
Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.静脉血栓栓塞症及其与 COVID-19 的关联：仍存在争议。
Medicina (Kaunas). 2020 Sep 27;56(10):506. doi: 10.3390/medicina56100506.
3
Venous thromboembolism in non-critically ill patients with COVID-19 infection.COVID-19 感染非危重症患者的静脉血栓栓塞症。
Thromb Res. 2020 Sep;193:166-169. doi: 10.1016/j.thromres.2020.07.033. Epub 2020 Jul 17.
4
Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening.新型冠状病毒肺炎患者的血栓形成事件：超声筛查的紧急呼吁。
Intensive Care Med. 2020 Jun;46(6):1121-1123. doi: 10.1007/s00134-020-06040-3. Epub 2020 Apr 22.
5
Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 pandemic.新型冠状病毒肺炎疫情期间疑似静脉血栓栓塞症的诊治。
J Vasc Surg Venous Lymphat Disord. 2020 Jul;8(4):526-534. doi: 10.1016/j.jvsv.2020.04.009. Epub 2020 Apr 17.
6
Incidence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients Receiving Prophylactic Anticoagulation.新冠肺炎危重症患者预防性抗凝治疗的静脉血栓栓塞症发生率。
Crit Care Med. 2020 Sep;48(9):e805-e808. doi: 10.1097/CCM.0000000000004472.
7
COVID-19 and venous thromboembolism: current insights and prophylactic strategies.2019冠状病毒病与静脉血栓栓塞症：当前见解与预防策略
Ann Med. 2020 Sep;52(6):239-242. doi: 10.1080/07853890.2020.1791355. Epub 2020 Jul 13.
8
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19.COVID-19 患者的动脉和静脉血栓栓塞并发症登记册。
J Am Coll Cardiol. 2020 Nov 3;76(18):2060-2072. doi: 10.1016/j.jacc.2020.08.070.
9
[Progression of dyspnea in COVID-19 patients: now what?].[新型冠状病毒肺炎患者呼吸困难的进展：现在该怎么办？]
Ned Tijdschr Geneeskd. 2020 Jul 2;164:D5116.
10
Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19.预测和处理重症新型冠状病毒肺炎的凝血功能障碍及血栓形成表现
CMAJ. 2020 Oct 5;192(40):E1156-E1161. doi: 10.1503/cmaj.201240. Epub 2020 Aug 16.
引用本文的文献
1
Characteristics of COVID-19 Patients Admitted to Intensive Care Unit in Multispecialty Hospital of Riyadh, Saudi Arabia: A Retrospective Study.沙特阿拉伯利雅得多专科医院重症监护病房收治的新冠肺炎患者特征：一项回顾性研究
Healthcare (Basel). 2023 Sep 8;11(18):2500. doi: 10.3390/healthcare11182500.
2
Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection.新型冠状病毒2019感染中肺组织因子上调、血栓调节蛋白缺失与免疫性血栓形成
EClinicalMedicine. 2021 Sep;39:101069. doi: 10.1016/j.eclinm.2021.101069. Epub 2021 Aug 6.
3
Modalities and Mechanisms of Treatment for Coronavirus Disease 2019.2019年冠状病毒病的治疗方式与机制
Front Pharmacol. 2021 Feb 8;11:583914. doi: 10.3389/fphar.2020.583914. eCollection 2020.
本文引用的文献
1
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
2
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.新型冠状病毒肺炎与血栓栓塞性疾病：预防、抗栓治疗与随访的相关问题：美国心脏病学会临床实践更新。
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
3
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
4
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
5
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
6
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.利伐沙班用于医疗疾病住院后的血栓预防。
N Engl J Med. 2018 Sep 20;379(12):1118-1127. doi: 10.1056/NEJMoa1805090. Epub 2018 Aug 26.
7
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score.一种用于识别住院医疗患者静脉血栓栓塞风险的风险评估模型：帕多瓦预测评分。
J Thromb Haemost. 2010 Nov;8(11):2450-7. doi: 10.1111/j.1538-7836.2010.04044.x.
Zotero 插件